Literature DB >> 27233050

The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology.

Güliz A Barkan1, Eva M Wojcik, Ritu Nayar, Spasenija Savic-Prince, Marcus L Quek, Daniel F I Kurtycz, Dorothy L Rosenthal.   

Abstract

The main purpose of urine cytology is to detect high-grade urothelial carcinoma. With this principle in mind, The Paris System (TPS) Working Group, composed of cytopathologists, surgical pathologists, and urologists, has proposed and published a standardized reporting system that includes specific diagnostic categories and cytomorphologic criteria for the reliable diagnosis of high-grade urothelial carcinoma. This paper outlines the essential elements of TPS and the process that led to the formation and rationale of the reporting system. TPS Working Group, organized at the 2013 International Congress of Cytology, conceived a standardized platform on which to base cytologic interpretation of urine samples. The widespread dissemination of this approach to cytologic examination and reporting of urologic samples and the scheme's universal acceptance by pathologists and urologists is critical for its success. For urologists, understanding the diagnostic criteria, their clinical implications, and limitations of TPS is essential if they are to utilize urine cytology and noninvasive ancillary tests in a thoughtful and practical manner. This is the first international/inclusive attempt at standardizing urinary cytology. The success of TPS will depend on the pathology and urology communities working collectively to improve this seminal paradigm shift, and optimize the impact on patient care.

Entities:  

Mesh:

Year:  2016        PMID: 27233050     DOI: 10.1097/PAP.0000000000000118

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  19 in total

1.  [Aftercare of non-muscle invasive bladder cancer].

Authors:  G B Schulz; B Schlenker; C G Stief
Journal:  Urologe A       Date:  2019-08       Impact factor: 0.639

2.  Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.

Authors:  Sasinya N Scott; Irina Ostrovnaya; Caroline M Lin; Nancy Bouvier; Bernard H Bochner; Gopakumar Iyer; David Solit; Michael F Berger; Oscar Lin
Journal:  Cancer Cytopathol       Date:  2017-03-24       Impact factor: 5.284

3.  Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.

Authors:  Vittorio Fasulo; Marco Paciotti; Massimo Lazzeri; Roberto Contieri; Paolo Casale; Alberto Saita; Giovanni Lughezzani; Pietro Diana; Nicola Frego; Pier Paolo Avolio; Piergiuseppe Colombo; Grazia Maria Elefante; Giorgio Guazzoni; Nicolò Maria Buffi; Michael Bates; Rodolfo Hurle
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

4.  Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.

Authors:  Sruthi Babu; Nam W Kim; Maoxin Wu; Ina Chan; Luisa F Escobar-Hoyos; Kenneth R Shroyer
Journal:  Am J Clin Pathol       Date:  2021-10-13       Impact factor: 5.400

5.  Primary transitional cell carcinoma of penis - A rare presentation.

Authors:  Jiasian Teh; Paul Kearns; Nathan Lawrentschuk
Journal:  Urol Case Rep       Date:  2018-11-23

6.  Is it time to standardize fine needle aspiration of gall bladder lesions and what city name it will be stamped with?

Authors:  Mousa A Al-Abbadi
Journal:  Cytojournal       Date:  2019-01-22       Impact factor: 2.091

7.  Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.

Authors:  Rania Bakkar; James Mirocha; Xuemo Fan; David P Frishberg; Mariza de Peralta-Venturina; Jing Zhai; Shikha Bose
Journal:  Cytojournal       Date:  2019-10-22       Impact factor: 2.091

Review 8.  Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers.

Authors:  Katherine E Smentkowski; Demetrius H Bagley; Scott G Hubosky
Journal:  Transl Androl Urol       Date:  2020-08

9.  Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Authors:  Toshikazu Tanaka; Tohru Yoneyama; Daisuke Noro; Kengo Imanishi; Yuta Kojima; Shingo Hatakeyama; Yuki Tobisawa; Kazuyuki Mori; Hayato Yamamoto; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Masakazu Tanaka; Shin-Ichiro Nishimura; Shizuka Kurauchi; Ippei Takahashi; Chikara Ohyama
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

10.  Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Authors:  Simeon U Springer; Chung-Hsin Chen; Maria Del Carmen Rodriguez Pena; Lu Li; Christopher Douville; Yuxuan Wang; Joshua David Cohen; Diana Taheri; Natalie Silliman; Joy Schaefer; Janine Ptak; Lisa Dobbyn; Maria Papoli; Isaac Kinde; Bahman Afsari; Aline C Tregnago; Stephania M Bezerra; Christopher VandenBussche; Kazutoshi Fujita; Dilek Ertoy; Isabela W Cunha; Lijia Yu; Trinity J Bivalacqua; Arthur P Grollman; Luis A Diaz; Rachel Karchin; Ludmila Danilova; Chao-Yuan Huang; Chia-Tung Shun; Robert J Turesky; Byeong Hwa Yun; Thomas A Rosenquist; Yeong-Shiau Pu; Ralph H Hruban; Cristian Tomasetti; Nickolas Papadopoulos; Ken W Kinzler; Bert Vogelstein; Kathleen G Dickman; George J Netto
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.